Administration of PAs into CCl4-induced rats’ liver fibrosis led to a significant (P < 0.05) amelioration at the levels of these apoptotic regulating proteins compared with CCL4-treated rats. The gene discussed is CCL4; the disease is Hepatic fibrosis.